AHA 2019: DAPA-HF - Dr Harriette Van Spall & Prof John McMurray

Dr Harriette Van Spall (McMaster University, Ontario, CA) & Prof John McMurray (Glasgow University Hospital, UK) discuss the Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF) - Sub-studies and sensitivity anaylses.

Filmed on site at AHA 2019 by Radcliffe Cardiology.
Videographer: Tom Green & Dominic Woodruff

See more videos here : https://www.radcliffecardiology.com/video-gallery
RC Academy : https://www.radcliffecardiology.com/radcliffe-cardiology-academy

radcliffecardiology.com is a dynamic, digitally-focused producer & publisher of Cardiovascular, Renal and Metabolic (CVRM) content for physicians worldwide. Radcliffe Cardiology also has a dedicated eLearning platform, RC Academy, which uses innovative platforms to host digital webinars, live case broadcasts and video roundtable discussions.